12-64466994-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PP3PP5BS2
The NM_013254.4(TBK1):c.452C>T(p.Ser151Phe) variant causes a missense change. The variant allele was found at a frequency of 0.0000763 in 1,612,542 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_013254.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TBK1 | NM_013254.4 | c.452C>T | p.Ser151Phe | missense_variant | Exon 5 of 21 | ENST00000331710.10 | NP_037386.1 | |
TBK1 | XM_005268809.2 | c.452C>T | p.Ser151Phe | missense_variant | Exon 5 of 21 | XP_005268866.1 | ||
TBK1 | XM_005268810.2 | c.452C>T | p.Ser151Phe | missense_variant | Exon 5 of 21 | XP_005268867.1 | ||
TBK1 | XR_007063071.1 | n.551C>T | non_coding_transcript_exon_variant | Exon 5 of 18 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152118Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000240 AC: 6AN: 250376Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135400
GnomAD4 exome AF: 0.0000835 AC: 122AN: 1460424Hom.: 0 Cov.: 30 AF XY: 0.0000881 AC XY: 64AN XY: 726552
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152118Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74306
ClinVar
Submissions by phenotype
Motor neuron disease Pathogenic:1
- -
not specified Uncertain:1
Variant summary: TBK1 c.452C>T (p.Ser151Phe) results in a non-conservative amino acid change located in the Protein kinase domain (IPR000719) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 2.4e-05 in 250376 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.452C>T has been reported in the literature in individuals affected with Amyotrophic lateral sclerosis, motor neuron disease, Dementia with Lewy bodies (Cirulli_2015, Black_2017, Orme_2020, Scaber_2023). These reports do not provide unequivocal conclusions about association of the variant with Autoinflammation with arthritis and vasculitis. At least one publication reports experimental evidence evaluating an impact on protein function and this variant affected protein function (Ye_2019). The following publications have been ascertained in the context of this evaluation (PMID: 28089114, 25700176, 25803835, 31996268, 37159497, 31748271). ClinVar contains an entry for this variant (Variation ID: 266068). Based on the evidence outlined above, the variant was classified as uncertain significance. -
TBK1-related disorder Uncertain:1
The TBK1 c.452C>T variant is predicted to result in the amino acid substitution p.Ser151Phe. This variant has been reported in a patient with dementia with Lewy bodies and in a patient with motor neuron disease (Table S3 Orme et al. 2020. PubMed ID: 31996268; Table S4 Black. 2017. PubMed ID: 28089114). However, pathogenicity of the c.452C>T variant was not confirmed through additional studies. This variant is reported in 0.0053% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Frontotemporal dementia and/or amyotrophic lateral sclerosis 4 Uncertain:1
This sequence change replaces serine, which is neutral and polar, with phenylalanine, which is neutral and non-polar, at codon 151 of the TBK1 protein (p.Ser151Phe). This variant is present in population databases (rs55824172, gnomAD 0.004%). This missense change has been observed in individual(s) with clinical features of amyotrophic lateral sclerosis and/or TBK1-related conditions (PMID: 21447600, 28089114, 31996268; Invitae). ClinVar contains an entry for this variant (Variation ID: 266068). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt TBK1 protein function with a negative predictive value of 95%. Experimental studies have shown that this missense change affects TBK1 function (PMID: 31748271). This variant disrupts the p.Ser151 amino acid residue in TBK1. Other variant(s) that disrupt this residue have been observed in individuals with TBK1-related conditions (Invitae), which suggests that this may be a clinically significant amino acid residue. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Frontotemporal dementia and/or amyotrophic lateral sclerosis 4;C4693542:Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 8;C5935634:Autoinflammation with arthritis and vasculitis Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at